Chairman and CEO

Global General Counsel

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Institution	Shares	Value	Change
Swedbank AB	1,274,897	$248M	DECREASED
Curated Wealth Partners	297,057	$3M	NEW
Vest Financial	204,403	$40M	INCREASED
Arbejdsmarkedets Tillaegspension	150,600	$29M	INCREASED
New York State Teachers Retirement System	121,228	$24M	DECREASED

Insider	Type	Shares	Value	Date
Michael J. Farrell (Chairman and CEO)	EXERCISE	4,991	$730K	2026-07-07
Michael J. Farrell (Chairman and CEO)	SELL	4,991	$1M	2026-07-07
Michael J. Farrell (Chairman and CEO)	EXERCISE	4,991	$730K	2026-06-08
Michael J. Farrell (Chairman and CEO)	SELL	4,991	$968K	2026-06-08
Michael J Rider (Global General Counsel)	SELL	268	$51K	2026-06-01

Member	Type	Amount	Date
Alan Armstrong (Republican)	PURCHASE	$1,001 - $15,000	2026-03-27
Ro Khanna (Democrat)	PURCHASE	$1,001 - $15,000	2026-05-01
Ro Khanna (Democrat)	PURCHASE	$1,001 - $15,000	2026-04-13

ResMed Inc. (RMD) Ownership & Trading Activity

Top Institutional Holders

Recent Insider Trades

Recent Congressional Trades